536 related articles for article (PubMed ID: 16020258)
1. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats.
Yu PK; Yu DY; Cringle SJ; Su EN
Curr Eye Res; 2005 Apr; 30(4):279-90. PubMed ID: 16020258
[TBL] [Abstract][Full Text] [Related]
2. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
4. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
5. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
6. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
7. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
8. [Role of Rho kinase in reorganization of the vascular endothelial cytoskeleton induced by rat burn serum].
Zheng HZ; Zhao KS; Huang QB
Zhonghua Shao Shang Za Zhi; 2005 Jun; 21(3):181-4. PubMed ID: 15996278
[TBL] [Abstract][Full Text] [Related]
9. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.
Kowluru RA; Odenbach S
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4161-6. PubMed ID: 15505070
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
12. Remodeling of retinal capillaries in the diabetic hypertensive rat.
Dosso AA; Leuenberger PM; Rungger-Brändle E
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2405-10. PubMed ID: 10476809
[TBL] [Abstract][Full Text] [Related]
13. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
Li W; Yanoff M; Liu X; Ye X
Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
[TBL] [Abstract][Full Text] [Related]
14. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
16. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes.
Zhang SX; Sima J; Wang JJ; Shao C; Fant J; Ma JX
Curr Eye Res; 2005 Aug; 30(8):681-9. PubMed ID: 16109649
[TBL] [Abstract][Full Text] [Related]
17. Rat strain-dependent susceptibility to ischemia-induced retinopathy associated with retinal vascular endothelial growth factor regulation.
Lu K; Zhou Y; Kaufman K; Mott R; Ma JX
J Mol Endocrinol; 2007 Apr; 38(4):423-32. PubMed ID: 17446232
[TBL] [Abstract][Full Text] [Related]
18. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
Pruneau D; Bélichard P; Sahel JA; Combal JP
Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
[TBL] [Abstract][Full Text] [Related]
19. Blockers of carbonic anhydrase can cause increase of retinal capillary diameter, decrease of extracellular and increase of intracellular pH in rat retinal organ culture.
Reber F; Gersch U; Funk RW
Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):140-8. PubMed ID: 12605269
[TBL] [Abstract][Full Text] [Related]
20. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat.
Hammes HP; Klinzing I; Wiegand S; Bretzel RG; Cohen AM; Federlin K
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2092-6. PubMed ID: 8491559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
